CORMEDIX INC. Current Assets
CORMEDIX INC. (CRMD) had Current Assets of $480.55 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-13
- 2026-06-30: Assets, Current $480.55M.
- 2026-03-31: Assets, Current $383.11M.
- 2025-12-31: Assets, Current $367.05M.
- 2025-09-30: Assets, Current $259.54M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $480.55M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $383.11M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $367.05M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $259.54M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $248.06M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $144.86M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $114.58M 10-K · filed 2026-03-05 | $114.58M 10-K · filed 2025-03-25 |
| 2024-09-30 | $73.15M 10-Q · filed 2024-10-30 | |
| 2024-06-30 | $53.19M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $63.41M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $79.45M 10-K · filed 2025-03-25 | |
| 2023-09-30 | $89.06M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $54.62M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $56.78M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $59.55M 10-K · filed 2024-03-12 | |
| 2022-09-30 | $59.66M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $65.36M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $62.50M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $66.47M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $72.99M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $79.69M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $83.06M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $48.18M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $38.87M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $24.13M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $27.28M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $29.35M 10-K · filed 2021-03-30 | |
| 2019-09-30 | $33.58M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $27.41M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $27.14M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $18.67M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $7.87M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $5.74M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $9.40M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $13.27M 10-K · filed 2019-05-29 | |
| 2017-09-30 | $13.85M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $21.09M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $14.87M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $21.83M 10-K · filed 2018-03-19 | |
| 2016-09-30 | $28.76M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $31.18M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $33.57M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $37.06M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $39.26M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $38.75M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $9.69M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $5.04M 10-K · filed 2016-03-15 | |
| 2014-09-30 | $6.78M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $8.19M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $9.71M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $2.92M 10-K · filed 2015-03-12 | |
| 2013-09-30 | $1.02M 10-Q/A · filed 2014-03-04 | |
| 2013-06-30 | $378.16K 10-Q/A · filed 2014-03-04 | |
| 2013-03-31 | $950.18K 10-Q/A · filed 2014-03-04 | |
| 2012-12-31 | $877.37K 10-K · filed 2014-03-31 | $1.14M 10-K · filed 2013-03-27 |
| 2012-09-30 | $1.24M 10-Q/A · filed 2013-03-27 | |
| 2012-06-30 | $999.81K 10-Q/A · filed 2012-09-06 | |
| 2012-03-31 | $2.01M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $2.53M 10-K/A · filed 2014-03-04 | |
| 2011-09-30 | $3.00M 10-Q · filed 2011-11-10 | |
| 2011-06-30 | $4.92M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $8.81M 10-K/A · filed 2012-04-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |